Participant flow
RECRUITMENT
100 patients were included in the trial (“intention to treat” population). Eight cases were deemed ineligible after randomization (six presented an OSCI grade greater than four, one was not a COVID patient, and one was included in a competing clinical trial). Thus, the “per protocol” population included 92 patients. (Flow chart of patient inclusion.Inclusion of cases started in April 2020 and ended in November 2020 after completing the scheduled recruitment. Median follow up was 16 months (range 1-23).